SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/17/15 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT), a biopharmaceutical company developing novel therapeutics for the treatment of grievous blood-based disorders with significant unmet needs, today announced the closing of its initial public ...
↧